CHLORDIAZEPOXIDE

Manufacturer
DIRECT RX
Effective date
2019-04-04
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-05-31 20:28:10

Label at a glance#

ProductCHLORDIAZEPOXIDE
Active ingredientCHLORDIAZEPOXIDE HYDROCHLORIDE
Label structure3 sections

Label contents#

Full prescribing information#

SPL MEDGUIDE SECTION

Chlordiazepoxide Hydrochloride
Capsules, USP C-IV

What is the most important information I should know about chlordiazepoxide?

•
Chlordiazepoxide is a benzodiazepine medicine. Taking benzodiazepines with opioid medicines, alcohol, or other central nervous system depressants (including street drugs) can cause severe drowsiness, breathing problems (respiratory depression), coma and death.
•
Chlordiazepoxide can make you sleepy or dizzy, and can slow your thinking and motor skills.

o
Do not drive, operate heavy machinery, or do other dangerous activities until you know how chlordiazepoxide affects you.
o
Do not drink alcohol or take other drugs that may make you sleepy or dizzy while taking chlordiazepoxide without first talking to your healthcare provider. When taken with alcohol or drugs that cause sleepiness or dizziness, chlordiazepoxide may make your sleepiness or dizziness much worse.
o
Do not take more chlordiazepoxide than prescribed.

What is chlordiazepoxide?

•
Chlordiazepoxide is a prescription medicine used:
o
to treat anxiety disorders
o
for the short-term relief of the symptoms of anxiety
o
to treat withdrawal symptoms of acute alcoholism
o
preoperatively to treat apprehension and anxiety
•
Chlordiazepoxide is a federal controlled substance (C-IV) because it can be abused or lead to dependence. Keep chlordiazepoxide in a safe place to prevent misuse and abuse. Selling or giving away chlordiazepoxide may harm others, and is against the law. Tell your healthcare provider if you have abused or been dependent on alcohol, prescription medicines or street drugs.
•
It is not known if chlordiazepoxide is safe and effective in children under 6 years of age.
•
It is not known if chlordiazepoxide is safe and effective for use for longer than 4 months.

Do not take chlordiazepoxide if you are allergic to chlordiazepoxide or to any of the ingredients in Chlordiazepoxide Hydrochloride Capsules. See the end of this Medication Guide for a complete list of ingredients in Chlordiazepoxide Hydrochloride Capsules.

Before you take chlordiazepoxide Hydrochloride, tell your healthcare provider about all of your medical conditions, including if you:

•
have or have had depression, mood problems, or suicidal thoughts or behavior
•
have a history of drug or alcohol abuse or addiction
•
have liver or kidney problems
•
are pregnant or plan to become pregnant. Chlordiazepoxide may harm your unborn baby. You and your healthcare provider should decide if you should take chlordiazepoxide while you are pregnant
•
are breastfeeding or plan to breastfeed. Chlordiazepoxide may pass into your breast milk and may harm your baby. Talk to your healthcare provider about the best way to feed your baby if you take chlordiazepoxide .

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

Taking chlordiazepoxide with certain other medicines can cause side effects or affect how well chlordiazepoxide or the other medicines work. Do not start or stop other medicines without talking to your healthcare provider.

How should I take chlordiazepoxide ?

•
Take chlordiazepoxide exactly as your healthcare provider tells you to take it. Your healthcare provider will tell you how much chlordiazepoxide to take and when to take it.
•
If you take too much chlordiazepoxide, call your healthcare provider or go to the nearest hospital emergency room right away.

What should I avoid while taking chlordiazepoxide ?

•
Chlordiazepoxide can cause you to be drowsy. Do not drive a car or operate heavy machinery until you know how chlordiazepoxide affects you.
•
You should not drink alcohol while taking chlordiazepoxide. Drinking alcohol can increase your chances of having serious side effects.

What are the possible side effects of chlordiazepoxide ?

Chlordiazepoxide may cause serious side effects, including:

•
See “What is the most important information I should know about chlordiazepoxide ?”
•
Abuse and dependence. Taking chlordiazepoxide can cause physical and psychological dependence. Physical and psychological dependence is not the same as drug addiction. Your healthcare provider can tell you more about the differences between physical and psychological dependence and drug addiction.
•
Withdrawal symptoms. You may have withdrawal symptoms if you stop taking chlordiazepoxide suddenly. Withdrawal symptoms can be serious and include seizures. Mild withdrawal symptoms include a depressed mood and trouble sleeping. Talk to your healthcare provider about slowly stopping chlordiazepoxide to avoid withdrawal symptoms.

The most common side effects of chlordiazepoxide include:

•
drowsiness

•
loss of control of body movements (ataxia)

•
confusion

These are not all the possible side effects of chlordiazepoxide . Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

How should I store Chlordiazepoxide Hydrochloride Capsules ?

•
Store Chlordiazepoxide Hydrochloride Capsules at room temperature between 68°F to 77°F (20°C to 25°C).
•
Keep Chlordiazepoxide Hydrochloride Capsules in a tightly closed container and out of the light.
•
Keep Chlordiazepoxide Hydrochloride Capsules and all medicines out of the reach of children.

General information about the safe and effective use of Chlordiazepoxide Hydrochloride Capsules.

Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide. Do not use Chlordiazepoxide Hydrochloride Capsules for a condition for which it was not prescribed. Do not give Chlordiazepoxide Hydrochloride Capsules to other people, even if they have the same symptoms that you have. It may harm them. You can ask your pharmacist or healthcare provider for information about Chlordiazepoxide Hydrochloride Capsules that is written for health professionals.

What are the ingredients in Chlordiazepoxide Hydrochloride Capsules?

Active ingredient: chlordiazepoxide hydrochloride

Inactive ingredients: FD&C Yellow No. 6 plus D&C Yellow No. 10 and either FD&C Blue No. 1 or FD&C Green No. 3 , D&C Yellow No. 10 and either FD&C Blue No. 1 plus FD&C Red No. 3 or FD&C Green No. 3 plus FD&C Red No. 40 , D&C Yellow No. 10 and either FD&C Green No. 3 or FD&C Blue No. 1 (10mg only), FD&C yellow #6 (10mg only), gelatin, hydrogenated vegetable oil, lactose anhydrous, methylparaben, microcrystalline cellulose, propylparaben, silicon dioxide, sodium lauryl sulfate and titanium dioxide

Distributed by:
Solco Healthcare U.S., LLC
Cranbury, NJ 08512


This Medication Guide has been approved by the U.S. Food and Drug Administration Issued: 12/2017

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

CHLORIAZEPOXIDE 25mgCHLORIAZEPOXIDE 25mg

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

593-30593-30

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
905495chlordiazePOXIDE HCl 25 MG Oral CapsulePSN2
905495chlordiazepoxide hydrochloride 25 MG Oral CapsuleSCD2

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
CHLORDIAZEPOXIDE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
632cace7-5e66-44d3-b8c3-9d6af8cdd96aProduct name520250623
6f1277d7-db3a-63fa-be84-d390d1482706Product name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
61919-593-302024-01-30C16284748780-11030e365-03e6-111a-e063-dadaa90a10e2CHLORIDIAZEPOXIDE 25mg

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
61919-593-30CHLORDIAZEPOXIDE30 in 1 BOTTLECAPSULE, GELATIN COATED302

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
61919-593CHLORDIAZEPOXIDE CAPSULE, GELATIN COATED [DIRECT RX]2Legacy NDC, 1 package rows20190405_2f1d49ad-13cb-2a23-e054-00144ff88e88.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
61919-593-30EA - Each61919-593013c7bce-842e-42d3-a507-5f03975b6fe912019-08-06
43547-253-10EA - Each43547-253ff99b563-7a26-4b4c-b517-e18d9f22db2112012-07-24

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 12 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
61919-59361919-593-30
43547-253

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 11 matching rows.

Source Document#

Source XML

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A085475-001LIBRIUMCHLORDIAZEPOXIDE HYDROCHLORIDE25MGCAPSULE / ORALABRLD, Approved before 1982

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
A085475-001AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08A085475-001LIBRIUM25MGCAPSULE / ORALABRLD, Approved before 198284e616aacf4f…
2026-08-18 06:07:402026-07A085475-001LIBRIUM25MGCAPSULE / ORALABRLD, Approved before 1982caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A085475-001LIBRIUM25MGCAPSULE / ORALABRLD, Approved before 1982011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A085475-001LIBRIUM25MGCAPSULE / ORALABRLD, Approved before 198231067a03dcf5…
2025-08-23 18:47 UTC2025-08A085475-001LIBRIUM25MGCAPSULE / ORALABRLD, Approved before 19826a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A085475-001LIBRIUM25MGCAPSULE / ORALABRLD, Approved before 1982fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A085475-001LIBRIUM25MGCAPSULE / ORALABRLD, Approved before 1982b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A085475-001LIBRIUM25MGCAPSULE / ORALABRLD, Approved before 198203ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A085475-001LIBRIUM25MGCAPSULE / ORALABRLD, Approved before 19822680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A085475-001LIBRIUM25MGCAPSULE / ORALABRLD, Approved before 19825bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A085475-001LIBRIUM25MGCAPSULE / ORALABRLD, Approved before 1982d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A085475-001LIBRIUM25MGCAPSULE / ORALABRLD, Approved before 1982d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A085475-001LIBRIUM25MGCAPSULE / ORALABRLD, Approved before 198279d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A085475-001LIBRIUM25MGCAPSULE / ORALABRLD, Approved before 1982301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A085475-001LIBRIUM25MGCAPSULE / ORALABRLD, Approved before 19821e350fbaab3a…
2024-05-31 18:47 UTC2024-05A085475-001LIBRIUM25MGCAPSULE / ORALABRLD, Approved before 19828072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A085475-001LIBRIUM25MGCAPSULE / ORALABRLD, RS, Approved before 19825c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A085475-001LIBRIUM25MGCAPSULE / ORALABRLD, RS, Approved before 19825d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A085475-001LIBRIUM25MGCAPSULE / ORALABRLD, RS, Approved before 19824b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A085475-001LIBRIUM25MGCAPSULE / ORALABRS, Approved before 198274a2ff9319b5…
2022-03-09 01:35 UTC2022-03A085475-001LIBRIUM25MGCAPSULE / ORALABRLD, RS, Approved before 1982bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A085475-001LIBRIUM25MGCAPSULE / ORALABRLD, RS, Approved before 1982782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A085475-001LIBRIUM25MGCAPSULE / ORALABRS, Approved before 198287673890dc5c…
2021-03-12 10:30 UTC2021-03A085475-001LIBRIUM25MGCAPSULE / ORALABRS, Approved before 19825aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A085475-001LIBRIUM25MGCAPSULE / ORALABRS, Approved before 19828869cabd3fbd…
2020-11-12 02:37 UTC2020-11A085475-001LIBRIUM25MGCAPSULE / ORALABRS, Approved before 1982c0c555d07b60…
2019-12-14 00:12 UTC2019-12A085475-001LIBRIUM25MGCAPSULE / ORALABRS, Approved before 19823f01610625f2…
2019-09-15 20:21 UTC2019-09A085475-001LIBRIUM25MGCAPSULE / ORALABRS, Approved before 1982b00525d2431f…
2019-07-19 19:46 UTC2019-07A085475-001LIBRIUM25MGCAPSULE / ORALABRS, Approved before 1982ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A085475-001LIBRIUM25MGCAPSULE / ORALABRLD, Approved before 19826a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A085475-001LIBRIUM25MGCAPSULE / ORALABRLD, Approved before 19821c564ffb4f44…
2023-12-20 04:57 UTC2023-12A085475-001LIBRIUM25MGCAPSULE / ORALABRLD, Approved before 1982ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A085475-001LIBRIUM25MGCAPSULE / ORALABRLD, Approved before 1982a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A085475-001LIBRIUM25MGCAPSULE / ORALABRLD, Approved before 19829b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A085475-001LIBRIUM25MGCAPSULE / ORALABRLD, Approved before 1982a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A085475-001LIBRIUM25MGCAPSULE / ORALABRLD, Approved before 19823f0d92c62455…
2023-05-13 08:27 UTC2023-05A085475-001LIBRIUM25MGCAPSULE / ORALABRLD, Approved before 1982053a50430f4f…
2023-01-26 05:58 UTC2023-01A085475-001LIBRIUM25MGCAPSULE / ORALABRLD, Approved before 19823bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A085475-001LIBRIUM25MGCAPSULE / ORALABRLD, Approved before 19823a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A085475-001LIBRIUM25MGCAPSULE / ORALABRLD, Approved before 1982f41ea6bd6efb…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-09-14 22:38:342026-08A085475-001AB184e616aacf4f…
2026-08-18 06:07:402026-07A085475-001AB1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A085475-001AB1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A085475-001AB131067a03dcf5…
2025-08-23 18:47 UTC2025-08A085475-001AB16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A085475-001AB1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A085475-001AB1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A085475-001AB103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A085475-001AB12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A085475-001AB15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A085475-001AB1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A085475-001AB1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A085475-001AB179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A085475-001AB1301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A085475-001AB11e350fbaab3a…
2024-05-31 18:47 UTC2024-05A085475-001AB18072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A085475-001AB15c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A085475-001AB15d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A085475-001AB14b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A085475-001AB174a2ff9319b5…
2022-03-09 01:35 UTC2022-03A085475-001AB1bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A085475-001AB1782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A085475-001AB187673890dc5c…
2021-03-12 10:30 UTC2021-03A085475-001AB15aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A085475-001AB18869cabd3fbd…
2020-11-12 02:37 UTC2020-11A085475-001AB1c0c555d07b60…
2019-12-14 00:12 UTC2019-12A085475-001AB13f01610625f2…
2019-09-15 20:21 UTC2019-09A085475-001AB1b00525d2431f…
2019-07-19 19:46 UTC2019-07A085475-001AB1ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A085475-001AB16a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A085475-001AB11c564ffb4f44…
2023-12-20 04:57 UTC2023-12A085475-001AB1ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A085475-001AB1a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A085475-001AB19b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A085475-001AB1a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A085475-001AB13f0d92c62455…
2023-05-13 08:27 UTC2023-05A085475-001AB1053a50430f4f…
2023-01-26 05:58 UTC2023-01A085475-001AB13bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A085475-001AB13a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A085475-001AB1f41ea6bd6efb…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
85b6b71f-54fb-8262-e053-2a91aa0a0f892f1d49ad-13cb-2a23-e054-00144ff88e882019-04-04Warnings, Adverse reactionsExact identifier
spl id: 85b6b71f-54fb-8262-e053-2a91aa0a0f89
spl set id: 2f1d49ad-13cb-2a23-e054-00144ff88e88

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.